16 Feb, 2024 Phase 2 Results from KARDIA-1 Study of Zilebesiran Published in the Journal of the American Medical Association
Posted at 12:45h
in Capella
Results from the Phase 2 KARDIA-1 study of zilebesiran, an investigational RNAi therapeutic targeting hepatic synthesis of angiotensinogen (AGT) in development for the treatment of hypertension, were published in the Journal of the American Medical Association (JAMA).
